Navigation Links
First-of-its-kind study creates new tool for targeted cancer drug development
Date:10/30/2011

ent kinases performing numerous functions. And the vast majority of kinase inhibitors will act on more than one kinase, and so have the potential to interfere with both cancer and the normal processes the body needs for health and survival. Not surprisingly, some of the kinase inhibitors approved for use in cancer cause significant side effects, such as cardiovascular problems.

Until the last few years, however, researchers simply didn't have the technology to observe which kinases a specific inhibitor acted upon. Recently, however, the company Reaction Biology Corporation developed a way to observe the suite of effects from one kinase inhibitor.

For the first time, Peterson and his team catalogued the activity of 178 kinase inhibitors against 300 kinases. The experiment was like observing what happens after shooting a scattergun at a wall of balloons, he says. Before, scientists could only tell if you popped one particular balloon now, however, they can see if other balloons were hit, as well. "We're essentially shining a light on the wall of balloons so we have a much better view of the balloons that were popped."

Not surprisingly, the researchers found that kinase inhibitors targeted multiple kinases, even some that appeared to be unrelated to each other. They have deposited this massive library of results on a free website so scientists studying kinases and inhibitors can learn more about their multiple interactions.

The fact that kinase inhibitors target multiple kinases may actually be a good thing, says Peterson. Initially, scientists had hoped to find an inhibitor that targets one specific kinase involved in cancer; now, they realize that cancer rarely results from one kinase. Instead, multiple kinases likely collaborate to produce the disease -- so to stop that process, you may have to hit all of those kinases together. "It may not be possible to develop a successful drug against one kinase," he says. Indeed, some kinase
'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Pediatric personalized medicine takes center stage at first-of-its-kind international conference
2. Mount Sinai Medical Center and ENT & Allergy Associates, LLP Create First-Of-Its-Kind Physician Portal
3. Johns Hopkins scientists begin first-of-its-kind research to create blood platelets from stem cells
4. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
5. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
6. TV drama can be more persuasive than news program, study finds
7. Study carried out into biological risks of eating reptiles
8. Neuroimaging study may pave way for effective Alzheimers treatments
9. Study finds racial gaps continue in heart disease awareness
10. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
11. First blinded study of venous insufficiency prevalence in MS shows promising results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Dr. Connie Casad has announced that she will be relocating ... 12200 Park Central Drive, Suite 200, Dallas, Texas 75251 on ... Aesthetics, Optimal Health and Wellness, her gynecology practice and concierge ... said, “The patients’ comfort and satisfaction are our primary goal. ... always feel like their needs are valued and recognized by ...
(Date:9/23/2014)... rapidly developing, bringing with its advances promises of ... and treatment interventions. Genetic tests are already ... and hepatitis c virus (HPC), and emerging research ... screen for an individual,s susceptibility to addiction to ... , While there appear to be many benefits ...
(Date:9/23/2014)... News) -- Few children who take medication for ... the rates vary six-fold across counties in the ... alone can manage symptoms for many children with ... receive behavioral therapy (psychotherapy), the Rand Corp. researchers ... than 1,500 counties across the United States that ...
(Date:9/23/2014)... Both patients and healthcare professionals believe diagnosis of ... greatly outweighs the potential disadvantages of subsequent radiologic ... according to a new study published in the ... , Diagnostic tests used for cancer screening programs ... for colorectal cancer with CT colonography, abdominal and ...
(Date:9/23/2014)... Boston, MA (PRWEB) September 23, 2014 ... announced that $50,000 investments each were made to ... the top two health ventures with business solutions to ... , SOURCE is a first-of-its-kind collaboration between The ... Investors' Circle that connects entrepreneurs with the investment ...
Breaking Medicine News(10 mins):Health News:Dr. Connie Casad Moving to New Office Location 2Health News:NYU-Mount Sinai Beth Israel study explores drug users' opinions on genetic testing 2Health News:Kids Taking ADHD Drugs Get Little Psychotherapy: Study 2Health News:Patients accept false-positives to achieve diagnostic sensitivity 2Health News:Patients accept false-positives to achieve diagnostic sensitivity 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 5
... talked about by only 20% of patients , , MONDAY, ... rheumatoid arthritis (RA) may be at increased risk for ... says a U.S. study that included 200 RA patients ... Betsy Sleath, of the University of North Carolina at ...
... Feb. 11 CAQH announced today,that the eligibility ... for Information Exchange (CORE) Phase I rules is ... Panel,s (HITSP) first set,of interoperability standards. These standards ... Mike Leavitt late last month., This recognition ...
... Feb. 11 The Employer Support of the ... Alliance to,its list of companies that provide extra-ordinary ... Reserves., National ESGR Executive Director Dr. Gordon ... gathering of the company,s leadership Sunday,in Westlake Village. ...
... Chesapeake Corporation,(NYSE: CSK ), a leading international ... supplier of printed pharmaceutical,leaflets in North America, today ... on Long Island, N.Y., and relocating,from its current ... "Our business has grown substantially since we moved ...
... at Childrens Hospital of Pittsburgh of UPMC have identified a ... the development of a vaccine to prevent and new therapies ... Research led by Jay K. Kolls, MD, chief of the ... identified for the first time the importance of a protein ...
... MINNEAPOLIS, Feb. 11 Uroplasty, Inc. (Amex:,UPI), ... and markets,innovative proprietary products for the treatment ... PC Neuromodulation System, its,proprietary, minimally invasive nerve ... bladder (OAB) symptoms, will be,featured in three ...
Cached Medicine News:Health News:Depression Rarely Discussed With RA Patients 2Health News:CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt 2Health News:CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt 3Health News:TriWest Named 'Top-Level' Employer of Guard, Reserve Troops 2Health News:Chesapeake to Expand and Relocate North American Pharmaceutical Packaging Operation 2Health News:Children's Hospital scientists identify possible target for prevention and treatment of pneumonia 2Health News:Studies on Urgent(R) PC to be Presented at the 2008 Society of Urologic Nurses and Associates Annual Symposium 2
(Date:9/23/2014)... , Sept. 23, 2014 Research ... the "Physician Office Laboratory Markets, 3rd Edition" ... This report, Physician Office Laboratory Markets is Kalorama,s ... IVD industry. Physician office laboratories are diverse in ... perform reimbursable, in-office pregnancy and glucose tests. Some ...
(Date:9/23/2014)... DUBLIN , September 23, 2014 /PRNewswire/ ... ) has announced the addition of the  ...  report to their offering.  ... injectable drug delivery market holds significant potential ... with vials and painful needles to the ...
(Date:9/23/2014)... -- SiteOne Therapeutics Inc. today announced the completion of its ... Management and Biobrit LLC, with additional investors Mission Bay ... financing positions SiteOne to advance its oral Na V ... its technology platform for long-acting local analgesics, pain diagnostics ... the financing, Lowell Sears (Sears Capital Management) ...
Breaking Medicine Technology:Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3Large Volume Wearable Injectors - 2nd Edition 2Large Volume Wearable Injectors - 2nd Edition 3Large Volume Wearable Injectors - 2nd Edition 4Large Volume Wearable Injectors - 2nd Edition 5SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 2SiteOne Therapeutics Completes $1.5M Initial Round of Equity Financing, Secures $1.4M NIH Grant 3
... 3 Australian researchers have developed gene expression ... colorectal growths from non-cancerous controls. , , ... conference in Chicago, the preliminary findings are the ... Flinders University and Australian healthcare company, Clinical Genomics ...
... Day 3 And All Subsequent Study Visits - , ... Pharma Co., Ltd., (DSP) announced today that positive results from ... of patients with schizophrenia have been published in The ... placebo-controlled trial, involving 180 patients with acute schizophrenia, evaluated a ...
Cached Medicine Technology:Advance in Bowel Cancer Test Research 2Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 2Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 3Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 4
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
... This convenient, procedural kit contains everything ... the methacholine challenge test quickly and efficiently: ... gas supply tubing, syringe and needle., ... available in the European Community., ,Intended ...
... Hand Held Nebulizer can be held at angles ... has a built in spill column, finger grooves ... medication setups and 7 feet of regular oxygen ... maintain small particle size and sustain optimum mist ...
Medicine Products: